Skip to content

Megna Michael R Insider Trading -- Recent SEC Form 4 Transactions

Megna Michael R (CIK 1464583) reported 48 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-12). Recent activity: Buy KNSA (11,280 shares), Sell KNSA (11,280 shares), Sell KNSA (5,350 shares), Buy KNSA (3,932 shares), Buy KNSA (7,209 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-11-12Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy11,280$200,333
2026-11-12Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell11,280$1.1M
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell5,350$522,909
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy3,932$43,645
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy7,209$86,292
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy4,065$72,194
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell6,030$553,976
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell6,831$633,712
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell9,508$895,654
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell3,705$351,456
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell3,145$302,172
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell1,691$164,213
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy4,689$50,454
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy279$9,346
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy3,932$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy2,558$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy2,362$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy2,644$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell5,531$438,498
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell4,600$369,380
2026-04-13Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell6,625$309,321
2026-04-08Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy3,932$3,932
2026-04-08Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell1,666$81,534
2026-04-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy372$8,988
2026-04-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy7,564$0

Source: SEC Form 4 filings · as of 2026-11-12